Ligustrazine Alleviates Blood–Brain Barrier Damage by Downregulating Expression of <scp>miR</scp>‐297c‐5p
In conclusion, the present findings provide new insights into regulating occludin by LSZ through downregulation of miR-297c-5p.
Authors
- Tian Li (ORCID: https://orcid.org/0000-0002-8281-4459)
- Shaoyu Guan
- Ruichen Jiang (ORCID: https://orcid.org/0000-0003-1616-1485)
- Xudong Wang (ORCID: https://orcid.org/0000-0002-8265-1485)
- Tong Chen (ORCID: https://orcid.org/0009-0002-9354-1641)
- Teng Ma (ORCID: https://orcid.org/0000-0001-6070-9976)
- Ping Yi (ORCID: https://orcid.org/0009-0005-1560-4602)
- Fang Wang (ORCID: https://orcid.org/0009-0000-3791-5544)
Institutions
- Beijing University of Chinese Medicine (CN)
- China-Japan Friendship Hospital (CN)
- Chinese PLA General Hospital (CN)
- Tianjin Nankai Hospital (CN)
- Ningxia Medical University (CN)
- Ningxia Medical University General Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1111/cns.70367
- Citations
- 1
- Primary Topic
- Barrier Structure and Function Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.84